Company research / OPRX

OptimizeRx Corp (OPRX)

CIK 0001448431 · Nasdaq · Services-Business Services, NEC

  • Sector Services
  • Incorporated NV
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, OptimizeRx Corp reported revenue of $109.43M. Revenue grew 18.8% from the prior annual period.

Key ratios (year ended 2025-12-31)

67.3%
Gross margin
10.7%
Operating margin
4.7%
Net margin
4.0%
Return on year-end equity
18.8%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-09-02

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.